Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor
Clinical trial NCT06057571 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06057571
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2025-07-27
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.